Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in IMMX — Immix Biopharma, Inc.

CIK 1423053 MIAMI, FL
Back to IMMX Full portfolio

Position in IMMX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$5,218,478
+$4,788,732 QoQ
Shares Held
506,157
+973.0% QoQ
Ownership
0.708%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 109 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMMX Over Time

Shares Held

Position Value (USD)

Derivatives in IMMX

reported options exposure · as of Jun 30, 2026
CallValue
$325,796
CallShares
31,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. IMMX ranks #136 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in IMMX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,218,478 506,157
2026-06-30 $325,796 31,600
2026-03-31 $429,746 47,173
2025-12-31 $394,017 75,338
2025-09-30 $187,677 89,798
2024-12-31 $1,980 900
2024-12-31 $25,300 11,500
2024-09-30 $13,261 8,900
2024-09-30 $1,788 1,200
2022-03-31 $52,328 21,713
2021-12-31 $94,247 26,474